These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17035734)

  • 21. A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab for pre-exposure use in healthy adults: results from a randomized controlled phase-II trial.
    Pichon S; Guinet-Morlot F; Minutello M; Donazzolo Y; Rouzier R; Chassard D; Fitoussi S; Hou V
    Vaccine; 2013 Apr; 31(18):2295-301. PubMed ID: 23510665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity and Safety of a Purified Vero Rabies Vaccine-Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 Trial.
    Pineda-Peña AC; Jiang Q; Petit C; Korejwo-Peyramond J; Donazzolo Y; Latreille M; Homery MC; Babin V; Benamor S; Pichon S; Guinet-Morlot F; Minutello AM
    Clin Infect Dis; 2024 Jun; 78(6):1748-1756. PubMed ID: 38478634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and immunogenicity study of a new purified chick embryo cell rabies vaccine Vaxirab-N (Pitman-Moore strain) manufactured in India.
    Ashwath Narayana DH; Madhusudana SN; Sampath G; Tripathy RM; Sudarshan MK; Gangaboraiah ; Ravish HS; Satapathy DM; Gowda G; Holla R; Ashwin BY; Padhi A; Manjula S; Patel PM
    Hum Vaccin Immunother; 2014; 10(1):120-5. PubMed ID: 24030586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and immunogenicity of a new purified vero cell rabies vaccine (PVRV) administered by intramuscular and intradermal routes in healthy volunteers.
    Kulkarni PS; Sapru A; D'costa PM; Pandit A; Madhusudana SN; Yajaman AB; Mangrule S; Gunale B; Bavdekar AR
    Vaccine; 2013 May; 31(24):2719-22. PubMed ID: 23583817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis.
    Preiss S; Chanthavanich P; Chen LH; Marano C; Buchy P; van Hoorn R; Vonk Noordegraaf M; Mukherjee P
    Expert Rev Vaccines; 2018 Jun; 17(6):525-545. PubMed ID: 29939085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immunogenicity and safety of vaccination with purified Vero cell rabies vaccine (PVRV) in China under a 2-1-1 regimen.
    Liu H; Huang G; Tang Q; Li J; Cao S; Fu C; Cao Q; Liu B; Pan H; Wang M
    Hum Vaccin; 2011 Feb; 7(2):220-4. PubMed ID: 21311216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study.
    Sampath G; Banzhoff A; Deshpande A; Malerczyk C; Arora AK; Vakil H; Preiss S
    Hum Vaccin Immunother; 2017 Jul; 13(7):1531-1538. PubMed ID: 28406752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe.
    Kamoltham T; Thinyounyong W; Phongchamnaphai P; Phraisuwan P; Khawplod P; Banzhoff A; Malerczyk C
    J Pediatr; 2007 Aug; 151(2):173-7. PubMed ID: 17643772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- and post-exposure rabies prophylaxis.
    Tantawichien T; Sibunruang S; Tantawichien T; Angsanakul J; Benjavongkulchai M; Limsuwan K; Udomchaisakul P; Khomvilai S; Sitprija V
    Expert Rev Vaccines; 2014 Dec; 13(12):1593-601. PubMed ID: 25315021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-year immunogenicity kinetics and safety of a purified chick embryo cell rabies vaccine and an inactivated Vero cell-derived Japanese encephalitis vaccine administered concomitantly according to a new, 1-week, accelerated primary series.
    Cramer JP; Jelinek T; Paulke-Korinek M; Reisinger EC; Dieckmann S; Alberer M; Bühler S; Bosse D; Meyer S; Fragapane E; Costantini M; Pellegrini M; Lattanzi M; Dovali C
    J Travel Med; 2016 Mar; 23(3):. PubMed ID: 26994987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and immunogenicity of the intradermal Thai red cross (2-2-2-0-1-1) post exposure vaccination regimen in the Indian population using purified chick embryo cell rabies vaccine.
    Chhabra M; Ichhpujani RL; Bhardwaj M; Tiwari KN; Panda RC; Lal S
    Indian J Med Microbiol; 2005 Jan; 23(1):24-8. PubMed ID: 15928417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized non-inferiority clinical study to assess post-exposure prophylaxis by a new purified vero cell rabies vaccine (Rabivax-S) administered by intramuscular and intradermal routes.
    Bose A; Munshi R; Tripathy RM; Madhusudana SN; Harish BR; Thaker S; Mahendra BJ; Gunale B; Gogtay NJ; Thatte UM; Mani RS; Manjunath K; George K; Yajaman AB; Sahai A; Dhere RM; Alex RG; Adhikari DD; Abhilash ; Raghava V; Kumbhar D; Behera TR; Kulkarni PS
    Vaccine; 2016 Sep; 34(40):4820-6. PubMed ID: 27554534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults.
    Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE
    Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV).
    Lang J; Cetre JC; Picot N; Lanta M; Briantais P; Vital S; Le Mener V; Lutsch C; Rotivel Y
    Biologicals; 1998 Dec; 26(4):299-308. PubMed ID: 10403033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax® Rabies) administered in a simulated rabies post-exposure regimen in healthy adults.
    Pichon S; Moureau A; Petit C; Kirstein JL; Sheldon E; Guinet-Morlot F; Minutello AM
    Vaccine; 2024 Apr; 42(10):2553-2559. PubMed ID: 38105138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity and safety of two-visit, intradermal pre-exposure rabies prophylaxis simultaneously administrated with chimeric live-attenuated Japanese encephalitis vaccine in children living in rabies and Japanese encephalitis endemic country.
    Angsuwatcharakon P; Ratananpinit N; Yoksan S; Saengseesom W; Sriaksorn R; Raksahket N; Tantawichien T
    Vaccine; 2020 Jul; 38(32):5015-5020. PubMed ID: 32522414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a new five-injection, two-site,intradermal schedule for purified chick embryo cell rabies vaccine: A randomized, open-label, active-controlled trial in healthy adult volunteers in India.
    Sudarshan MK; Madhusudana SN; Mahendra BJ; Ashwath Narayana DH; Ananda Giri MS; Popova O; Vakil HB
    Curr Ther Res Clin Exp; 2005 Jul; 66(4):323-34. PubMed ID: 24672132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals.
    Quiambao BP; Dimaano EM; Ambas C; Davis R; Banzhoff A; Malerczyk C
    Vaccine; 2005 Feb; 23(14):1709-14. PubMed ID: 15705476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized open-label trial of 2-dose or 3-dose pre-exposure rabies prophylaxis among Thai children.
    Janewongwirot P; Jantarabenjakul W; Anugulruengkitt S; Anunsittichai O; Saengseesom W; Buranapraditkun S; Sophonphan J; Wacharachaisurapol N; Jitrungruengnij N; Pancharoen C; Puthanakit T
    Vaccine; 2019 Aug; 37(36):5307-5313. PubMed ID: 31358408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity and effectiveness of post-exposure rabies prophylaxis with a new chromatographically purified Vero-cell rabies vaccine (CPRV): a two-stage randomised clinical trial in the Philippines.
    Quiambao BP; Lang J; Vital S; Montalban CG; Le Mener V; Wood SC; Miranda E
    Acta Trop; 2000 Feb; 75(1):39-52. PubMed ID: 10708006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.